Alex Aravanis is a seasoned Chief Technology Officer with a strong background in research and product development in the biotech industry. With a PhD in Electrical Engineering from Stanford University, he has held key leadership roles at companies like Illumina and GRAIL, Inc. His expertise in high-intensity sequencing and multi-cancer detection has led to groundbreaking publications in top scient...